SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-021049
Filing Date
2023-07-28
Accepted
2023-07-28 16:54:33
Documents
16
Period of Report
2023-09-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vtgn20230727_def14a.htm DEF 14A 648808
2 graph01.jpg GRAPHIC 34888
3 graph02.jpg GRAPHIC 33227
4 pc1.jpg GRAPHIC 190647
5 pc2.jpg GRAPHIC 107462
6 vtgn20230714_def14aimg001.jpg GRAPHIC 3915
7 vtgn20230714_def14aimg002.jpg GRAPHIC 5374
8 vtgn20230714_def14aimg003.jpg GRAPHIC 3915
9 vtgn20230714_def14aimg004.jpg GRAPHIC 3915
10 vtgn20230714_def14aimg005.jpg GRAPHIC 6132
11 vtgn20230714_def14aimg006.jpg GRAPHIC 7270
12 vtgn20230714_def14aimg007.jpg GRAPHIC 2797
13 vtgn20230714_def14aimg008.jpg GRAPHIC 5983
14 vtgn20230714_def14aimg009.jpg GRAPHIC 5250
15 vtgn20230714_def14aimg010.jpg GRAPHIC 5671
16 vtgn20230714_def14aimg011.jpg GRAPHIC 5374
  Complete submission text file 0001437749-23-021049.txt   1232768
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37761 | Film No.: 231123829
SIC: 2834 Pharmaceutical Preparations